Summary:
CTT is conducting a research study to compare the safety and effectiveness of an investigational medication to placebo (inactive substance) in individuals with mild to moderate ulcerative colitis.
Qualified Participants Must:
• Be 18 years of age or older
•
Be diagnosed with ulcerative colitis
•
Currently be taking Mesalamine or its equivalent
• Additional criteria may apply
Qualified Participants May Receive:
Compensation up to $400 is available for time and travel.